Stroke thrombolysis: slow progress.
Caplan
Louis R
LR
D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009316:National Institutes of Health (U.S.); D020521:Stroke / Q000175:diagnosis / Q000188:drug therapy*; D015912:Thrombolytic Therapy / Q000009:adverse effects / Q000639:trends*; D014057:Tomography, X-Ray Computed; D014481:United States; D014486:United States Food and Drug Administration
D005343:Fibrinolytic Agents